1News 1News — your global news briefing, coming soon on iOS & Android
Coming Soon
1News 1News
Top Business Entertainment Sports Technology Politics Science Lifestyle
Back to Business
Wedbush downgrades Compass Therapeutics stock rating on FDA trial concerns
Business September 22, 2026 at 8:56 PM

Wedbush downgrades Compass Therapeutics stock rating on FDA trial concerns

Investing.com
Read at Investing.com
More Stories
Talos Energy stock rises on $420M Gulf of America asset deal
Business
Talos Energy stock rises on $420M Gulf of America asset deal
🇺🇸 Investing.com 43m ago
Trading Day: Oil slips, Nasdaq rips
Business
Trading Day: Oil slips, Nasdaq rips
🇺🇸 Investing.com 43m ago
Gran Tierra secures bondholder consent for indenture amendments
Business
Gran Tierra secures bondholder consent for indenture amendments
🇺🇸 Investing.com 43m ago
1News
Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play
1News 1News

Your global news briefing — 300+ sources, 12 countries, 10 languages.

Support 1News Settings Search AI Info

Privacy Policy · Terms of Service

© 2026 1News. The world's news, curated for you.